Posts Tagged: merck


Merck agrees to $625 million payment, royalties to Bristol-Myers Squibb for sales of Keytruda cancer treatment

On January 20th, NYC-based drugmaker Bristol-Myers Squibb Co. (NYSE:BMY) and Kenilworth, NJ-based pharmaceutical firm Merck & Co. (NYSE:MRK) announced that the two companies had entered into …
By Steve Brachmann
8 months ago 0

Merck subsidiary Idenix wins $2.54B in HCV treatment suit against Gilead in largest U.S. patent infringement verdict ever

On Thursday, December 15th, a subsidiary of Kenilworth, NJ-based pharmaceutical developer Merck & Co. (NYSE:MRK) was awarded $2.54 in royalty damages in a case involving one of the …
By Steve Brachmann
9 months ago 1

A look at treatments for hepatitis C, America’s top infectious disease killer

The FDA has been pretty active this year in approving new tests and treatments designed to help identify and eliminate the hepatitis C virus in patients. Swiss …
By Steve Brachmann
1 year ago 1

Merck, Pfizer and Eli Lilly patenting to stay ahead of patent cliff

The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here …
By Steve Brachmann
2 years ago 0

Merck seeks patents on cancer treatments, medications for Alzheimer’s

Merck & Co. (NYSE: MRK), which is headquartered in Whitehouse Station, NJ, and also does business under the name Merck Sharp & Dohme MSD, is one of …
By Steve Brachmann
3 years ago 0

Top 10 Patents for 2014

Today, we’re picking the best inventions for which corporations from the Companies We Follow series have actually earned patent rights from the U.S. Patent and …
By Steve Brachmann
3 years ago 7

Merck Patents Drugs for Metabolic Disorders & Alzheimer’s

Our survey of the patents recently issued by the USPTO to Merck showed us a great deal of innovation in the field of metabolic disorders and conditions, …
By Steve Brachmann
3 years ago 0

Pharma Update: News for April 2014

What follows below is a review of some of the pharma news stories that caught my attention during the month of April 2014. Supreme Court Denies Teva's Request …
By Gene Quinn
3 years ago 0

Biotech and Pharma Update: News for December 2013

What follows below is a review of some of the biotech and pharma news stories that caught my attention during the month of December 2013. Fitch Puts Negative …
By Gene Quinn
4 years ago 0

Pharma Update July 2013: FDA, Preemption & SCOTUS

The FDA is following through on plans to issue a proposed rule to revise regulations to allow generic drugmakers to update labeling. The rule would update current …
By Ed Silverman
4 years ago 0

Patent Business: Deals, Acquisitions & Licenses Vol. 1

Merck and AstraZeneca Agree to Amend Partnership - Theradiag Acquires Innovative MicroRNA Technology Platform - 8x8 Sells Patent Family - MPEG LA Announces Call for Patents Essential …
By Gene Quinn
5 years ago 1

Valid but Not Infringed, Merck’s Loses Blockbuster Nasonex®

Last week, on Friday, June 15, 2012, Merck (NYSE: MRK) announced the U.S. District Court for the District of New Jersey (Judge Peter G. Sheridan) ruled against the …
By Gene Quinn
5 years ago 4

CorporateCounsel.com Names Top 10 IP Litigation Wins of 2009

The victories selected represent a diverse array of wins, which a press release announcing the Top 10 list says is due to "the differing objectives of IP litigation …
By Gene Quinn
8 years ago 0

Merck Wins Singulair Victory Over Teva

Earlier today, Judge Garrett Brown of the United States Federal District Court for the District of New Jersey, issued an Order and Findings of Fact and Conclusions …
By Gene Quinn
8 years ago 0